| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/1992 | EP0470431A2 Use of fosfomycin pharmaceutically acceptable salts as a topical cicatrizer |
| 02/12/1992 | EP0470317A1 Use of a derivative of 1,3,7-trimethylxanthine for the treatment of memory disorders, senile intellectual disorders and Alzheimer's disease |
| 02/12/1992 | EP0470252A1 Anti-hiv drug |
| 02/12/1992 | EP0470251A1 Liquid prostaglandin composition |
| 02/12/1992 | EP0470176A1 Substituted 3-amino chromans. |
| 02/12/1992 | EP0470144A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours. |
| 02/12/1992 | EP0470127A1 Pcp receptor ligands and the use thereof |
| 02/12/1992 | CN1058598A New linker for bioactive agents |
| 02/12/1992 | CN1058595A Thioalkylthio cephalosporin derivatives |
| 02/12/1992 | CN1058594A Imidazo (4,5-c) pyridines as antiosteoporotic agents |
| 02/12/1992 | CN1058593A Process and intermediates for beta-lactams having aminothiazole (iminoxyacetic acid) acetic acid sidechains |
| 02/12/1992 | CN1058586A Process for preparing phylloporphyrin |
| 02/12/1992 | CN1058585A Sulfur-substituted mevinic acid derivatives |
| 02/12/1992 | CN1058532A Process for preparing composition containing oral cephalosporin crystal hydrate |
| 02/12/1992 | CN1015462B Method for preparing 6-(substd.) methylenepenicillanic acids or 1,1-dioxide and derivatives thereof |
| 02/12/1992 | CN1015461B Method for preparing 6-(substd.) methylenepenicillanic acid and 1,1-dioxide, and derivatives thereof |
| 02/12/1992 | CN1015460B Process for preparing asymmetrical ester derivatives of 1,4-dihydropyridine-3,5-dicarboxylic acid |
| 02/12/1992 | CN1015459B Quinazolone compound and its preparation method |
| 02/12/1992 | CN1015458B Process for preparing heterocyclic compounds |
| 02/12/1992 | CN1015457B 5-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine |
| 02/12/1992 | CN1015453B Process for preparing novel alpha, alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide' n-oxides |
| 02/12/1992 | CN1015452B Process for preparing butenoic acid amide compounds |
| 02/12/1992 | CN1015418B Process for preparing a new medicinal composition with cooperating effect |
| 02/12/1992 | CN1015417B Process for preparing medicine combination containing formamide derivatives |
| 02/11/1992 | WO1992002224A1 Antiparkinson mao reversible inhibitor |
| 02/11/1992 | WO1992002213A1 Methods of preventing or decreasing tissue damage by novel antioxidants and free radical scavengers |
| 02/11/1992 | US5087743 Treatment of skin disorders |
| 02/11/1992 | US5087732 Glutaric acid derivatives and preparation thereof |
| 02/11/1992 | US5087712 Derivatives of platinum (ii) with polymethylsiloxane, method for preparing same and antitumor agent based thereon |
| 02/11/1992 | US5087697 Therapeutic nucleosides |
| 02/11/1992 | US5087640 Potassium channel openers; hypotensive agents, coronary vasodilators |
| 02/11/1992 | US5087639 Preventing CNS toxicity of acivicin when used with four large neutral amino acids |
| 02/11/1992 | US5087637 Skin disorders |
| 02/11/1992 | US5087636 Method to destroy malignant cells in mononuclear cell populations |
| 02/11/1992 | US5087633 Use of a glycine B partial agonist for memory and learning enhancement or treatment of a cognitive disorder |
| 02/11/1992 | US5087630 Method for the treatment of a hyponatremic disease |
| 02/11/1992 | US5087629 Pharmacologically active pyrazolopyridine compounds |
| 02/11/1992 | US5087628 Cognition activators |
| 02/11/1992 | US5087627 Agent for treatment of disorders of the cerebro-neural transmission system |
| 02/11/1992 | US5087626 Method for increasing the weight gain and improving the feed utilization efficiency of livestock |
| 02/11/1992 | US5087624 Administering to increase lean body mass in mammals |
| 02/11/1992 | US5087623 Reducing hyperglycemia and stabilizing the level of serum glucose in humans |
| 02/11/1992 | US5087622 Method of controlling T3 and T4 levels in vivo with cobalt porphyrins |
| 02/11/1992 | US5087621 Microbiocides |
| 02/11/1992 | US5087620 Controlled dermal penetration enhancement using imidazoles |
| 02/11/1992 | US5087619 For treatment of skin or gland disorders; antitumor agents |
| 02/11/1992 | US5087617 Methods and compositions for treatment of cancer using oligonucleotides |
| 02/11/1992 | US5087454 Containing croscarmellose sodium and sodium lauryl sulfate; stable dissolution profile |
| 02/11/1992 | US5087452 Therapeutic product based on an organic compound of silicon and polycarboxylated polyamine, particularly useful in the treatment of atheroma |
| 02/11/1992 | US5087451 Treatment of periodontal disease |
| 02/11/1992 | US5087442 Containing iron citrate compound, sodium carbonate and/or bicarbonate, acid neutralizing agent |
| 02/11/1992 | US5087441 Protection against chemically-induced kidney damage by methimazole |
| 02/11/1992 | US5087438 Method for affecting intracellular and extracellular electric and magnetic dipoles |
| 02/11/1992 | CA2089145A1 Methods of preventing or decreasing tissue damage by novel antioxidants and free radical scavengers |
| 02/11/1992 | CA2067170A1 Antiparkinson mao reversible inhibitor |
| 02/11/1992 | CA2048899A1 Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment |
| 02/11/1992 | CA2048841A1 Corticoid-17-alkylcarbonates substituted in the 17-position, process for their preparation and pharmaceuticals containing them |
| 02/11/1992 | CA2048810A1 Method for treatment of bone wasting diseases |
| 02/11/1992 | CA2048809A1 Heterocyclic imidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/11/1992 | CA1295786C Cytotoxic substances from the marine cyanophyte hormothamnion enteromorphoides grunow |
| 02/11/1992 | CA1295624C Process for the manufacture of novel guanidinium aspartates |
| 02/11/1992 | CA1295617C 1-¬(1,1-diphenyl)-1-alkenyl| pierazine derivatives, method of preparation and pharmaceutical compositions in which they are present |
| 02/11/1992 | CA1295616C Antiarrhythmic agents |
| 02/11/1992 | CA1295615C 2-amino-3-aroyl- -oxobenzenebutanoic acids and esters |
| 02/11/1992 | CA1295614C 9-(phosphonylmethoxyalkyl)adenines, the method of preparation and utilization thereof |
| 02/11/1992 | CA1295613C 4-benzyl-1-(2h)-phthalazinone derivatives |
| 02/11/1992 | CA1295612C Nitrogen containing derivatives of epipodophyllotoxin glucosides |
| 02/10/1992 | WO1992002223A1 Process for formulating a solid oral dosage form of loperamide compounds |
| 02/10/1992 | CA2048541A1 Synergistic composition of 2-(2-bromo-2-nitroethenyl) furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof |
| 02/10/1992 | CA2048540A1 42-oxorapamycin |
| 02/10/1992 | CA2047884A1 Method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
| 02/10/1992 | CA2047249A1 Process |
| 02/10/1992 | CA2038066A1 (benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma |
| 02/09/1992 | WO1992002488A1 Propylamine derivatives |
| 02/09/1992 | WO1992002217A1 Antimalarial compositions |
| 02/09/1992 | WO1992002208A1 Stable doxorubicin/liposome composition |
| 02/09/1992 | CA2088985A1 Propylamine derivatives |
| 02/09/1992 | CA2088975A1 Stable doxorubicin/liposome composition |
| 02/09/1992 | CA2048714A1 Acid addition salts of optically active alaninanilide compounds and pharmaceutical compositions containing the same |
| 02/09/1992 | CA2048518A1 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| 02/09/1992 | CA2048315A1 Process for preparing enantiomers of compounds having muscarinic activity |
| 02/07/1992 | WO1992002520A1 Oxazolidine dione derivatives |
| 02/07/1992 | WO1992002502A1 N-hydrocarbyl-4-substituted piperidines, their preparation and use as calcium blocking agents |
| 02/07/1992 | WO1992002501A1 3-substituted piperidine derivatives |
| 02/07/1992 | WO1992002235A1 Calcium and trace mineral supplements |
| 02/07/1992 | CA2093146A1 Oxazolidine dione derivatives |
| 02/07/1992 | CA2088491A1 N-hydrocarbyl-4-substituted piperidines, their preparation and use as calcium blocking agents |
| 02/07/1992 | CA2088490A1 3-substituted piperidine derivatives |
| 02/06/1992 | WO1992001803A1 Method for hydroxylation of a cyclic or acyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilisation of such compositions for the preparation of drugs |
| 02/06/1992 | WO1992001730A1 Novel polyamines and method for preparation thereof |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001708A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/06/1992 | WO1992001697A1 Novel substituted thiazolyl and substituted pyridinyl derivatives |
| 02/06/1992 | WO1992001696A1 Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 02/06/1992 | WO1992001695A1 Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 02/06/1992 | WO1992001694A1 New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii¿b? |
| 02/06/1992 | WO1992001692A1 Method for preparing sulphonylpristinamycin ii¿b? |
| 02/06/1992 | WO1992001682A1 Acetylene derivatives having lipoxygenase inhibitory activity |
| 02/06/1992 | WO1992001676A1 Quinolonecarboxylic acid derivative |
| 02/06/1992 | WO1992001675A2 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions |